Patents by Inventor Matthew C. Parker

Matthew C. Parker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENGINEERED CELLS FOR PRODUCING OF THERAPEUTIC AGENTS TO BE DELIVERED BY A HYBRID BIOELECTRONIC DEVICE
    Publication number: 20240254507
    Abstract: An engineered cell expressing a therapeutic agent and a reporter agent, the engineered cell comprising a first transgene containing a light sensing DNA sequence encoding a light sensing protein, and a second transgene containing a calcium activated promoter, a therapeutic agent DNA encoding a therapeutic agent, and a reporter agent DNA encoding a reporter agent.
    Type: Application
    Filed: April 21, 2022
    Publication date: August 1, 2024
    Inventors: Omid Veiseh, Jacob Robinson, Jonathan Rivnay, Isaac Hilton, Samantha T. Fleury, Matthew C. Parker, Jacob H. Goell, Jing Li, Kaiyuan Wang
  • HYBRID BIOELECTRONIC/ENGINEERED CELL IMPLANTABLE SYSTEM FOR THERAPEUTIC AGENTS DELIVERY AND APPLICATIONS THEREOF
    Publication number: 20240207508
    Abstract: A bioelectronic implantable device includes engineered cells and an electronically controlled stimulator that regulates a quantity and timing of therapeutic agent produced by the engineered cells.
    Type: Application
    Filed: April 21, 2022
    Publication date: June 27, 2024
    Inventors: Jonathan Rivnay, Omid Veiseh, Jacob Robinson, Samantha T. Fleury, Matthew C. Parker, Fatima T. Alrashdan